On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a ...

Jim Cramer’s life and career have been a fascinating blend of ambition, resilience, and personal growth. Born in Wyndmoor, ...

CNBC's Jim Cramer unpacked President Donald Trump 's actions over the past few days, and concluded that investors should heed ...

Amgen stock skidded late Tuesday after the biotech behemoth said the FDA placed one of its obesity treatments on clinical ...

Bridgewater Associates' flagship fund Pure Alpha posted a gain of 8.2% in January, in a period when investors navigated a ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

CNBC’s Jim Cramer unpacked Monday’s market action, saying investors shouldn’t be so shocked by President Donald Trump’s steep ...

We recently published a list of Jim Cramer’s Bold Predictions About These 10 Tech Stocks. In this article, we are going to ...

CoinShares research director James Butterfill highlighted that the news surrounding DeepSeek alone triggered $530 million in outflows on January 27. Despite the overall market unease, Bitcoin ETPs ...

Cramer endorsed Bitcoin's potential, calling it "a great thing to have in your portfolio" at a time when BTC as trading at ...

On CNBC's "Mad Money Lightning Round," Jim Cramer said Summit Therapeutics is "obviously just a very big spec." ...